XSNX logo

NovAccess Global Inc. Stock Price

OTCPK:XSNX Community·US$12.4k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

XSNX Share Price Performance

US$0.0002
-0.01 (-98.17%)
US$0.0002
-0.01 (-98.17%)
Price US$0.0002

XSNX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

NovAccess Global Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$1.9m

Other Expenses

-US$1.9m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.031
0%
0%
-30.6%
View Full Analysis

About XSNX

Founded
1997
Employees
n/a
CEO
Dwain Morris-Irvin
WebsiteView website
www.novaccessglobal.com

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

Recent XSNX News & Updates

Recent updates

No updates